Comera Life Sciences Holdings, Inc.: debt financing — Comera Life Sciences raises $1.5M via 12% senior secured convertible notes due 2024 with warrants

Comera Life Sciences Holdings, Inc.

$1.5M aggregate principal of 12.0% Senior Secured Convertible Notes due Dec 29, 2024; convertible at $0.055/share, interest payable monthly.
Warrants issued for 200% of Note Shares, exercisable immediately at $0.055/share for 5 years.
Purchasers include existing major stockholders Charles Cherington and trusts controlled by David Soane (each >20% prior).
Purchasers granted Share Purchase right to buy all outstanding stock at $0.0825 or 1.5x closing price; exclusivity through Dec 2024.
Notes secured by first priority lien on substantially all assets; subject to affirmative/negative covenants.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Comera Life Sciences Holdings, Inc. incurred senior notes of $1,500,000 in aggregate principal amount with certain purchasers at 12.0% maturing December 29, 2024.

Instrument: senior notes
Principal: $1,500,000 in aggregate principal amount
Counterparty: certain purchasers
Rate: 12.0%
Maturity: December 29, 2024
Event: incurrence

Exact text from the filing

$1,500,000 in aggregate principal amount of 12.0% Senior Secured Convertible Notes due 2024

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Comera Life Sciences Holdings, Inc. entered into Securities Purchase Agreement with certain purchasers valued at $1,500,000 (effective 2023-12-29).

Action: entry
Agreement: equity purchase
Counterparty: certain purchasers
Value: $1,500,000
Effective: 2023-12-29

Exact text from the filing

On December 29, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain purchasers described below (collectively, the “Purchasers” and each, a “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the “Private Placement”) $1,500,000 in aggregate principal amount of 12.0% Senior Secured Convertible Notes due 2024

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0000950170-23-073905

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.